**REPLAY** Radiopharma Day Recap Webinar with Matt Taylor & Andrew Tsai

Research evidence excerpt

**REPLAY** Radiopharma Day Recap Webinar with Matt Taylor & Andrew Tsai

USA | Medical Supplies & Devices EquityJuneResearch9, 2026

**REPLAY** Radiopharma Day Recap Webinar

with Matt Taylor & Andrew Tsai

Matt Taylor & Andrew Tsai discuss key takeaways from Radiopharma Day,

which featured experts in areas of medicine being most affected by changes in

the Radiopharma landscape, including cancer, cardiac, and neurological care. .

Here, we discuss the latest innovations in therapeutics and diagnostics that are

shaping the present and future of the field.

**See Radiopharma Day Takeaways replay HERE **

Hosts:

Matthew Taylor, Jefferies US Medical Supplies & Devices Analyst•

Andrew Tsai, Jefferies Biotechnology Small & Midcap Analyst•

Matt Taylor & Andrew Tsai discuss key takeaways from our Radiopharma Day, which included

expert doctor/KOLs in areas of medicine being most affected by changes in the Radiopharma

landscape, including cancer (e.g. prostate and GEP-NETs), cardiac, and neurological care. We also

discuss the latest innovations in therapeutics and diagnostics that are helping to shape the present

and future of the field.

Wrap-up Notes:

RDx Day: Rapid Brain PET Growth; Alz Tx Still Very Early; GEHC, LLY and LNTH ++•

RDx Day: Cardiac Imaging Momentum; PET & FFR-CT Taking Share•

RDx Day: PSMA PET Growth to Continue; LNTH Share Leadership Unch•

RDx Day: 5+ KOL Tidbits on the Evolving GEP-NET Radiopharma Landscape•

Matthew Taylor, CFA * | Equity Analyst

1 (212) 778-8721 | matt.taylor@jefferies.com

Andrew Tsai * | Equity Analyst

(415) 229-1566 | atsai@jefferies.com

Michael Sarcone, CFA * | Equity Analyst

1 (212) 778-8606 | msarcone@jefferies.com

Young Li * | Equity Analyst

+1 (212) 778-8671 | young.li@jefferies.com

Michael Toomey, CFA * | Equity Analyst